Scarica l'app Stockscreener
5.05
25.62%
1.03
Dopo l'orario di chiusura:
5.00
-0.05
-0.99%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$4.02
Aprire:
$4.11
Volume 24 ore:
524.24K
Relative Volume:
3.18
Capitalizzazione di mercato:
$93.61M
Reddito:
$117.59M
Utile/perdita netta:
$-74.85M
Rapporto P/E:
-1.2096
EPS:
-4.175
Flusso di cassa netto:
$-34.25M
1 W Prestazione:
+17.44%
1M Prestazione:
+35.75%
6M Prestazione:
+39.89%
1 anno Prestazione:
-74.20%
Intervallo 1D:
$4.07
$5.25
Intervallo di 1 settimana:
$4.00
$5.25
Portata 52W:
$3.00
$21.36
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
5.05 | 93.61M | 117.59M | -74.85M | -34.25M | -4.175 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains? - Yahoo Finance
Outset Medical Inc (OM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Outset Medical Inc (OM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Outset Medical Inc (OM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Outset Medical Inc (OM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Outset Medical Inc (OM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Outset Medical Inc (OM) Institutional Confidence - TradingKey
Outset Medical Inc (OM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Outset Medical (OM) inks $40M multi‑year HCA deal for Tablo systems - Stock Titan
Outset Medical Inc (OM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Outset Medical Secures Multi‑Year HCA Hemodialysis Agreement - TipRanks
Outset Medical, Inc. (OM) reports Q1 loss, lags revenue estimates - MSN
Outset Medical Inc. (OM) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesEnergy Earnings Report - newsline.com
Have Insiders Sold Outset Medical Shares Recently? - simplywall.st
Outset Medical Inc. Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 3.17%Share Dilution Risk - newsline.com
Outset Medical CFO Renee Gaeta sells $87,299 in stock By Investing.com - Investing.com South Africa
Outset Medical CFO Renee Gaeta sells $87,299 in stock - Investing.com UK
Law firm investigates Outset Medical officers for possible shareholder duty breaches - Pluang
Director at Outset Medical (OM) receives 10,667-share stock grant - Stock Titan
Outset Medical (NYSE: OM) director granted 10,667 RSUs in new equity award - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU equity grant - Stock Titan
Outset Medical (OM) director receives 10,667-share RSU-based award - Stock Titan
Outset Medical (OM) director receives 10,667-share equity award grant - Stock Titan
Outset Medical director granted 10,667 shares | OM Insider Trading - Stock Titan
Outset Medical (OM) CFO tax-related share sale follows RSU vesting - Stock Titan
Outset Medical (NASDAQ: OM) reports 2026 shareholder meeting vote results - Stock Titan
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Barchart.com
BML Capital Management, LLC's Outset Medical Inc(OM) Holding History - GuruFocus
Outset Medical names Derick Elliott commercial chief - Investing.com
OM (NASDAQ) Form 144 notice — 32,856 shares settled from RSUs - Stock Titan
DaVita Gains 21.4% in Three Months: How Should You Play the Stock? - TradingView
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Outset Medical's Marc Nash to Depart as Executive Vice President, R&D, Operations and Service - TradingView
[8-K] Outset Medical, Inc. Reports Material Event - Stock Titan
Outset Medical, Inc. Announces Resignation of Marc Nash from Executive Vice President, R&D, Operations and Service, Effective June 5, 2026 - marketscreener.com
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical Inc. (OM) Edges Higher as Stock Holds Above Key Support LevelHigh Volume Stocks - The Legal Advocate
Outset Medical Q1 2026 Earnings: EPS Misses Estimates as Stock Inches HigherProduct Revenue Analysis - newsline.com
Outset Medical Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherEarnings Yield Analysis - thelegaladvocate.com
OM Q1 2026 Earnings: EPS Misses Estimates as Outset Medical Posts Wider-Than-Expected Loss; Stock Edges Up - newsline.com
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical (OM) Price Target Decreased by 38.83% to 16.06 - MSN
Outset Medical: General counsel Brottem sells $9,760 in shares - Investing.com India
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock - Investing.com India
Outset Medical EVP Marc Nash sells $5,853 in common stock By Investing.com - Investing.com South Africa
Outset Medical: General counsel Brottem sells $9,760 in shares By Investing.com - Investing.com South Africa
Outset Medical CEO Leslie Trigg sells $12,746 in OM shares By Investing.com - Investing.com Nigeria
Outset Medical (OM) EVP sells 1,582 shares in tax-related ‘sell to cover’ - Stock Titan
BML Investment Partners takes 13.6% stake in Outset Medical (OM) - Stock Titan
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):